Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
07/01/2014 | US8765790 Positive allosteric modulators of nicotinic acetylcholine receptor |
07/01/2014 | US8765789 2-pyridinecarboxamide derivatives |
07/01/2014 | US8765788 Tricyclic inhibitors of hydroxysteroid dehydrogenases |
07/01/2014 | US8765787 Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen |
07/01/2014 | US8765785 Solifenacin salts |
07/01/2014 | US8765784 Positive allosteric modulators of MGLUR2 |
07/01/2014 | US8765783 Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation |
07/01/2014 | US8765782 Indole derivatives as selective androgen receptor modulators (SARMS) |
07/01/2014 | US8765781 Bis-carbazole DNA intercalating agents for antitumor therapy |
07/01/2014 | US8765780 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
07/01/2014 | US8765779 Tricyclic derivatives and their pharmaceutical use and compositions |
07/01/2014 | US8765778 Rifamycin derivatives |
07/01/2014 | US8765777 Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection |
07/01/2014 | US8765776 Antihypertensive pharmaceutical composition |
07/01/2014 | US8765775 Anti-angiogenic compounds |
07/01/2014 | US8765774 3-arylquinazolin-4-one compounds for combating invertebrate pests |
07/01/2014 | US8765773 Substituted hydroxamic acids and uses thereof |
07/01/2014 | US8765772 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
07/01/2014 | US8765771 Condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
07/01/2014 | US8765770 Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as potassium channel modulators |
07/01/2014 | US8765769 Ring-fused 4-aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases |
07/01/2014 | US8765768 Heterocyclic compounds and their uses |
07/01/2014 | US8765767 Positive allosteric modulators of mGluR2 |
07/01/2014 | US8765766 Pyrimidine derivatives which are antagonists of the vitronectin receptor |
07/01/2014 | US8765765 Metabolites of (thio) carbamoyl-cyclohexane derivatives |
07/01/2014 | US8765764 2-acylaminothiazole derivative or salt thereof |
07/01/2014 | US8765763 Substituted piperazines as CGRP antagonists |
07/01/2014 | US8765762 Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome |
07/01/2014 | US8765761 6-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a syk inhibitor |
07/01/2014 | US8765760 [1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterases |
07/01/2014 | US8765759 Monocyclic CGRP receptor antagonists |
07/01/2014 | US8765758 Compositions and methods for eye whitening |
07/01/2014 | US8765754 Pyrrolotriazine compounds |
07/01/2014 | US8765752 3-hydroxyisothiazole 1-oxide derivatives |
07/01/2014 | US8765751 Compounds useful as inhibitors of ATR kinase |
07/01/2014 | US8765750 Piperazine compound having a PGDS inhibitory effect |
07/01/2014 | US8765749 1,6-disubstituted indole compounds as protein kinase inhibitors |
07/01/2014 | US8765748 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer |
07/01/2014 | US8765747 Fused 2-aminothiazole compounds |
07/01/2014 | US8765746 Heteroaryls and uses thereof |
07/01/2014 | US8765745 Compounds for enzyme inhibition |
07/01/2014 | US8765744 Azaspirohexanones |
07/01/2014 | US8765743 Compounds |
07/01/2014 | US8765742 Crystalline methylthioninium chloride hydrates |
07/01/2014 | US8765741 5,6-dihydro-1H-pyridin-2-one compounds |
07/01/2014 | US8765740 Cytotoxic benzodiazepine derivatives |
07/01/2014 | US8765739 Azetidine compound and pharmaceutical use thereof |
07/01/2014 | US8765738 Carbazole compounds and therapeutic uses of the compounds |
07/01/2014 | US8765737 Methods and compositions for preparing and purifying noribogaine |
07/01/2014 | US8765736 Benzenesulfonamide compounds and the use thereof |
07/01/2014 | US8765735 Isoxazolines as inhibitors of fatty acid amide hydrolase |
07/01/2014 | US8765734 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors |
07/01/2014 | US8765733 Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands |
07/01/2014 | US8765732 Aryl- or heteroaryl-substituted benzene compounds |
07/01/2014 | US8765731 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
07/01/2014 | US8765730 1-hydroxyimino-3-phenyl-propanes |
07/01/2014 | US8765729 Cancer therapy |
07/01/2014 | US8765728 [1,5]-diazocin derivatives |
07/01/2014 | US8765727 Macrocyclic compounds and their use as kinase inhibitors |
07/01/2014 | US8765726 Use of pyridone derivatives in the prevention or treatment of tissue or organ toxicity induced by cytotoxic agents and radiation |
07/01/2014 | US8765724 Methods of using ophthalmic compositions comprising povidone-iodine |
07/01/2014 | US8765723 Analogues of cilostazol |
07/01/2014 | US8765722 Inhibitors of flaviviridae viruses |
07/01/2014 | US8765721 Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof |
07/01/2014 | US8765720 Combination therapy for the treatment of multiple myeloma |
07/01/2014 | US8765719 Therapeutic drug for adult T-cell leukemia |
07/01/2014 | US8765717 Meloxicam and glucosamine formulation and uses thereof |
07/01/2014 | US8765716 Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process |
07/01/2014 | US8765714 Sulphated hyaluronic acid for treating degenerative osteoarthritis |
07/01/2014 | US8765713 Method for determination of sensitivity to anti-cancer agent |
07/01/2014 | US8765712 Agent for preventing and treating pityriasis versicolor |
07/01/2014 | US8765711 Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage |
07/01/2014 | US8765710 2′,4′-substituted nucleosides as antiviral agents |
07/01/2014 | US8765698 Methods and products for reawakening retrocyclins |
07/01/2014 | US8765697 Pesticide compositions exhibiting enhanced activity |
07/01/2014 | US8765696 Steroid compound |
07/01/2014 | US8765694 Method for treating obesity |
07/01/2014 | US8765693 Method of inhibiting premature aging of human skin caused by exposure to infrared radiation |
07/01/2014 | US8765692 Modified-galactosyl ceramides for staining and stimulating natural killer T cells |
07/01/2014 | US8765691 Osmolytes for the treatment of allergic or viral respiratory diseases |
07/01/2014 | US8765690 Treatment of cancer with glufosfamide in patients not receiving insulin therapy |
07/01/2014 | US8765685 Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP) |
07/01/2014 | US8765681 IAP BIR domain binding compounds |
07/01/2014 | US8765680 Method for administering omega-conopeptide |
07/01/2014 | US8765676 Calcium sensing receptor modulating compounds and pharmaceutical use thereof |
07/01/2014 | US8765674 Methods useful in the treatment of bone resorption diseases |
07/01/2014 | US8765668 Methods of synthesis of β-aminobutyryl substituted compounds |
07/01/2014 | US8765665 Albumin-free factor VIII formulations |
07/01/2014 | US8765657 Antimicrobially effective use solutions comprising combinations of isothiazolones and amines |
07/01/2014 | US8765432 Targeted drug phosphorylcholine polymer conjugates |
07/01/2014 | US8765376 Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of CF-associated mutant cystic fibrosis transmembrane conductance regulator |
07/01/2014 | US8765198 Anti-stretch mark active agent, and compositions containing same |
07/01/2014 | US8765194 Natural—topical analgesic and anti-inflammatory composition |
07/01/2014 | US8765185 Granules for pharmaceutical preparations, methods and apparatus for their production |
07/01/2014 | US8765178 Controlled release formulations and associated methods |
07/01/2014 | US8765177 Bioadhesive progressive hydration tablets |
07/01/2014 | US8765175 Sustained release formulation of nalbuphine |
07/01/2014 | US8765164 Poly(ester urea) polymers and methods of use |
07/01/2014 | US8765157 Topical skin composition comprising shea butter, jojoba oil, petroleum jelly, glycerin, and zinc oxide |
07/01/2014 | US8765156 Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound |